Net Income (Loss) Attributable to Parent in USD of Cannabis Bioscience International Holdings, Inc. from Q3 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cannabis Bioscience International Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2010 to Q3 2025.
  • Cannabis Bioscience International Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 31 Aug 2025 was -$82.6K, a 8.31% decline year-over-year.
  • Cannabis Bioscience International Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 31 Aug 2025 was -$555K, a 1.7% decline year-over-year.
  • Cannabis Bioscience International Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$549K, a 15.7% increase from 2023.
  • Cannabis Bioscience International Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$651K, a 36.9% increase from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Cannabis Bioscience International Holdings, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$555K -$82.6K -$6.34K -8.31% 01 Jun 2025 31 Aug 2025 10-Q 22 Oct 2025
Q2 2025 -$549K -$212K -$75.8K -55.8% 01 Mar 2025 31 May 2025 10-K 22 Sep 2025
Q1 2025 -$473K -$181K +$27.9K +13.4% 01 Dec 2024 28 Feb 2025 10-Q/A 09 May 2025
Q4 2024 -$501K -$79.5K +$44.9K +36.1% 01 Sep 2024 30 Nov 2024 10-Q/A 09 May 2025
Q3 2024 -$546K -$76.3K +$105K +58% 01 Jun 2024 31 Aug 2024 10-Q 22 Oct 2025
Q2 2024 -$651K -$136K +$140K +50.8% 01 Mar 2024 31 May 2024 10-K 22 Sep 2025
Q1 2024 -$791K -$209K +$115K +35.6% 01 Dec 2023 29 Feb 2024 10-Q/A 09 May 2025
Q4 2023 -$907K -$124K +$95.5K +43.4% 01 Sep 2023 30 Nov 2023 10-Q/A 09 May 2025
Q3 2023 -$1M -$182K +$30.2K +14.3% 01 Jun 2023 31 Aug 2023 10-Q/A 09 May 2025
Q2 2023 -$1.03M -$276K 01 Mar 2023 31 May 2023 10-K 16 Sep 2024
Q1 2023 -$325K 01 Dec 2022 28 Feb 2023 10-Q 22 Apr 2024
Q4 2022 -$220K 01 Sep 2022 30 Nov 2022 10-Q 22 Apr 2024
Q3 2022 -$212K 01 Jun 2022 31 Aug 2022 10-Q 22 Apr 2024
Q1 2012 -$1.24M +$427K +25.6% 01 Dec 2011 29 Feb 2012 10-Q 20 Apr 2012
Q4 2011 $1.81M -$3.07M -63% 01 Sep 2011 30 Nov 2011 10-Q 23 Jan 2012
Q3 2011 $3.1M -$876K -22% 01 Jun 2011 31 Aug 2011 10-Q/A 07 Nov 2011
Q1 2011 -$1.67M 01 Dec 2010 28 Feb 2011 10-Q 20 Apr 2012
Q4 2010 $4.88M 01 Sep 2010 30 Nov 2010 10-Q 23 Jan 2012
Q3 2010 $3.98M 01 Jun 2010 31 Aug 2010 10-Q/A 07 Nov 2011

Cannabis Bioscience International Holdings, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$549K +$103K +15.7% 01 Jun 2024 31 May 2025 10-K 22 Sep 2025
2023 -$651K +$381K +36.9% 01 Jun 2023 31 May 2024 10-K 22 Sep 2025
2022 -$1.03M 01 Jun 2022 31 May 2023 10-K 16 Sep 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.